After 1 year, patients in the dietary intervention, on average, lowered HbA1c from 7.6 to 6.3%, lost 12% of their body weight, and reduced diabetes medicine use. 94% of patients who were prescribed insulin reduced or stopped their insulin use, and sulfonylureas were eliminated in all patients. Additionally, the new dietary intervention patients also improved markers for inflammation and liver function.
Participants in the typical ineffective diabetes management group had no changes to HbA1c, weight or diabetes medicine use over the year.
This suggests the novel dietary model studied here using dietary carbohydrate restriction and continuous remote care can safely support adults with Type 2 Diabetes to lower HbA1c, weight, and medicine use.